SELEX技术及Aptamer研究的新进展

综述了近几年指数富集的配体系统进化(SELEX)技术的改良与寡核苷酸配基(aptamer)研究应用方面的新进展.Aptamer是指利用SELEX(systematicevolutionofligandsbyexponentialenrichment)技术,从随机寡核苷酸文库中筛选获得的能够与靶分子特异结合的短单链寡核苷酸配基,通常具有纳摩尔到皮摩尔的亲和力.高通量筛选的技术特点与aptamer精确识别、易体外合成与修饰等特性,使得aptamer在分析化学与生物医药研究方面具有广阔的应用前景.

Advances in The SELEX Technique and Aptamers

Aptamers are short single-stranded nucleic acid ligands that are capable of binding almost any targets with low nano- to picomolar affinities and exceptional specificities. They are selected out of a large combinatorial oligonucleotide library through an in vitro evolution process termed SELEX (systematic evolution of ligands by exponential enrichment). The unique advantages of high-throughput screening technique and aptamers in precise recognition as well as easiness to synthesis and modification bring aptamers a bright prospect in analytical chemistry, biology and medicine research. The recent advances in the SELEX technique and aptamers are reviewed.